Vericel Corp Ord Stock Investor Sentiment
| VCEL Stock | USD 56.71 0.55 0.96% |
About 60% of Vericel Corp's investor base is looking to short. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that many traders are alarmed. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
Panic Vs Confidence
40
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vericel Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vericel Corp Ord.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Vericel Historical Sentiment
Although Vericel Corp's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Vericel, such as negative comments on social media and news outlets, may cause fear in the market and push Vericel Corp's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Vericel.
Vericel |
Vericel Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Vericel Corp that are available to investors today. That information is available publicly through Vericel media outlets and privately through word of mouth or via Vericel internal channels. However, regardless of the origin, that massive amount of Vericel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vericel Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vericel Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vericel Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vericel Corp alpha.
Vericel Corp Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Rubino Alan L of 3200 shares of Vericel Corp subject to Rule 16b-3 | 08/30/2024 |
2 | Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 10.95 subject to Rule 16b-3 | 09/03/2024 |
3 | Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3 | 09/11/2024 |
4 | Disposition of 5834 shares by Gilman Steven C of Vericel Corp at 45.54 subject to Rule 16b-3 | 09/18/2024 |
5 | Acquisition by Jonathan Siegal of 937 shares of Vericel Corp subject to Rule 16b-3 | 09/30/2024 |
6 | Disposition of 568 shares by Jonathan Siegal of Vericel Corp at 41.9 subject to Rule 16b-3 | 10/01/2024 |
7 | Vericel Corp director sells shares worth over 235k | 10/04/2024 |
8 | Acquisition by Gilman Steven C of 5833 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 10/16/2024 |
9 | Strength Seen in Prothena Can Its 15.0 percent Jump Turn into More Strength | 10/29/2024 |
10 | Vericel Corp Q3 2024 Earnings Report Preview What To Look For | 11/06/2024 |
11 | Vericel Corp Q3 2024 Earnings Revenue Hits 57.9M, EPS at -0.02, Surpassing Estimates | 11/07/2024 |
12 | Vericel Earns Buy Rating from HC Wainwright | 11/08/2024 |
13 | Heres Why Momentum in Vericel Should Keep going | 11/11/2024 |
14 | Disposition of 2500 shares by Zerbe Robert L Md of Vericel Corp at 57.5 subject to Rule 16b-3 | 11/12/2024 |
15 | Acquisition by Zerbe Robert L Md of 2500 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 11/13/2024 |
16 | Acquisition by Sean Flynn of 1474 shares of Vericel Corp at 16.25 subject to Rule 16b-3 | 11/18/2024 |
17 | Vericel Meets 80-Plus Relative Strength Rating Benchmark | 11/20/2024 |
Check out Vericel Corp Hype Analysis, Vericel Corp Correlation and Vericel Corp Performance. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.